IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v30y2012i2p127-131.html
   My bibliography  Save this article

Why Not Real Economics?

Author

Listed:
  • F. Reed Johnson

Abstract

No abstract is available for this item.

Suggested Citation

  • F. Reed Johnson, 2012. "Why Not Real Economics?," PharmacoEconomics, Springer, vol. 30(2), pages 127-131, February.
  • Handle: RePEc:spr:pharme:v:30:y:2012:i:2:p:127-131
    DOI: 10.2165/11593350-000000000-00000
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.2165/11593350-000000000-00000
    Download Restriction: Access to full text is restricted to subscribers.

    File URL: https://libkey.io/10.2165/11593350-000000000-00000?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. John Bridges & Elizabeth Kinter & Lillian Kidane & Rebekah Heinzen & Colleen McCormick, 2008. "Things are Looking up Since We Started Listening to Patients," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 1(4), pages 273-282, October.
    2. Mohan V. Bala & Gary A. Zarkin, 2000. "Are QALYs an appropriate measure for valuing morbidity in acute diseases?," Health Economics, John Wiley & Sons, Ltd., vol. 9(2), pages 177-180, March.
    3. repec:reg:rpubli:98 is not listed on IDEAS
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mark Sculpher & Karl Claxton, 2012. "Real Economics Needs to Reflect Real Decisions," PharmacoEconomics, Springer, vol. 30(2), pages 133-136, February.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Charles Cunningham & Ken Deal & Yvonne Chen, 2010. "Adaptive Choice-Based Conjoint Analysis," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 3(4), pages 257-273, December.
    2. Ateesha Mohamed & A. Hauber & Maureen Neary, 2011. "Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma," PharmacoEconomics, Springer, vol. 29(11), pages 977-988, November.
    3. Birch, Stephen & Gafni, Amiram, 2003. "Economics and the evaluation of health care programmes: generalisability of methods and implications for generalisability of results," Health Policy, Elsevier, vol. 64(2), pages 207-219, May.
    4. F. Reed Johnson & Juan Marcos Gonzalez & John J. Sheehan & Shelby D. Reed, 2023. "How Much Better is Faster? Value Adjustments for Health-Improvement Sequences," PharmacoEconomics, Springer, vol. 41(8), pages 845-856, August.
    5. Tristan Snowsill, 2023. "Modelling the Cost-Effectiveness of Diagnostic Tests," PharmacoEconomics, Springer, vol. 41(4), pages 339-351, April.
    6. Elizabeth Kinter & Thomas Prior & Christopher Carswell & John Bridges, 2012. "A Comparison of Two Experimental Design Approaches in Applying Conjoint Analysis in Patient-Centered Outcomes Research," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 5(4), pages 279-294, December.
    7. Greenberg, Dan & Bakhai, Ameet & Neumann, Peter J. & Cohen, David J., 2004. "Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study," Health Policy, Elsevier, vol. 70(2), pages 207-216, November.
    8. Ateesha Mohamed & A. Brett Hauber & F. Johnson & Cheryl Coon, 2010. "Patient Preferences and Linear Scoring Rules for Patient-Reported Outcomes," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 3(4), pages 217-227, December.
    9. Axel C. Mühlbacher & Andrew Sadler & Christin Juhnke, 2021. "Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(3), pages 425-443, April.
    10. Axel Mühlbacher & Uwe Junker & Christin Juhnke & Edgar Stemmler & Thomas Kohlmann & Friedhelm Leverkus & Matthias Nübling, 2015. "Chronic pain patients’ treatment preferences: a discrete-choice experiment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(6), pages 613-628, July.
    11. Deborah Marshall & John Bridges & Brett Hauber & Ruthanne Cameron & Lauren Donnalley & Ken Fyie & F. Reed Johnson, 2010. "Conjoint Analysis Applications in Health — How are Studies being Designed and Reported?," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 3(4), pages 249-256, December.
    12. Hammitt, James K. & Haninger, Kevin, 2017. "Valuing nonfatal health risk as a function of illness severity and duration: Benefit transfer using QALYs," Journal of Environmental Economics and Management, Elsevier, vol. 82(C), pages 17-38.
    13. Teresa Kauf & Ateesha Mohamed & A. Hauber & Derek Fetzer & Atiya Ahmad, 2012. "Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 5(4), pages 265-278, December.
    14. Sonik, Rajan Anthony & Creedon, Timothy B. & Progovac, Ana Maria & Carson, Nicholas & Delman, Jonathan & Delman, Deborah & Lê Cook, Benjamin, 2020. "Depression treatment preferences by race/ethnicity and gender and associations between past healthcare discrimination experiences and present preferences in a nationally representative sample," Social Science & Medicine, Elsevier, vol. 253(C).
    15. Wagner, Todd H. & Hu, Teh-wei & Duenas, Grace V. & Kaplan, Celia P. & Nguyen, Bang H. & Pasick, Rena J., 2001. "Does willingness to pay vary by race/ethnicity? An analysis using mammography among low-income women," Health Policy, Elsevier, vol. 58(3), pages 275-288, December.
    16. Morteza Chalak & Veronique Florec & Atakelty Hailu & Fiona Gibson & David Pannell, 2017. "Integrating non-market values in economic analyses of flood mitigation: a case study of the Brown Hill and Keswick creeks catchment in Adelaide," Working Papers 256513, University of Western Australia, School of Agricultural and Resource Economics.
    17. John Slof, 2012. "Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on evidence from the ‘Act when Mild’ study," Applied Health Economics and Health Policy, Springer, vol. 10(3), pages 201-215, May.
    18. Halme, Merja & Kallio, Markku, 2011. "Estimation methods for choice-based conjoint analysis of consumer preferences," European Journal of Operational Research, Elsevier, vol. 214(1), pages 160-167, October.
    19. John Bridges & Elizabeth Kinter & Annette Schmeding & Ina Rudolph & Axel Mühlbacher, 2011. "Can Patients Diagnosed with Schizophrenia Complete Choice-Based Conjoint Analysis Tasks?," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 4(4), pages 267-275, December.
    20. George Van Houtven & John Powers & Amber Jessup & Jui‐Chen Yang, 2006. "Valuing avoided morbidity using meta‐regression analysis: what can health status measures and QALYs tell us about WTP?," Health Economics, John Wiley & Sons, Ltd., vol. 15(8), pages 775-795, August.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:30:y:2012:i:2:p:127-131. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.